Disease progression baseline, 2, 5, 8, 11, 14, 20, and 26 months after study treatment [clinicaltrials_resource:f748f8c837ceea946981ae1fb84cebe6]

Disease progression baseline, 2, 5, 8, 11, 14, 20, and 26 months after study treatment [clinicaltrials_resource:f748f8c837ceea946981ae1fb84cebe6]

Change in tumor size based on CT or MRI of the head/neck/chest as compared to baseline measurement.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f748f8c837ceea946981ae1fb84cebe6
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer [clinicaltrials:NCT00798655]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Disease progression baseline, 2, 5, 8, 11, 14, 20, and 26 months after study treatment [clinicaltrials_resource:f748f8c837ceea946981ae1fb84cebe6]

Change in tumor size based on CT or MRI of the head/neck/chest as compared to baseline measurement.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:f748f8c837ceea946981ae1fb84cebe6
Bio2RDF identifier
f748f8c837ceea946981ae1fb84cebe6
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f748f8c837ceea946981ae1fb84cebe6
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
baseline, 2, 5, 8, 11, 14, 20, and 26 months after study treatment
description
Change in tumor size based on ...... pared to baseline measurement.
identifier
clinicaltrials_resource:f748f8c837ceea946981ae1fb84cebe6
title
Disease progression baseline, 2, 5, 8, 11, 14, 20, and 26 months after study treatment
@en
inDataset
type
label
Disease progression baseline, ...... 8f8c837ceea946981ae1fb84cebe6]
@en